An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Albiglutide in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Albiglutide (Primary) ; Warfarin
- Indications Embolism; Thrombosis; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 23 Sep 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 23 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.